KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Payables (2016 - 2025)

Historic Payables for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $3.0 billion.

  • Colgate Palmolive's Payables rose 3972.8% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 3972.8%. This contributed to the annual value of $2.5 billion for FY2024, which is 2154.83% up from last year.
  • Colgate Palmolive's Payables amounted to $3.0 billion in Q3 2025, which was up 3972.8% from $3.4 billion recorded in Q2 2025.
  • Colgate Palmolive's Payables' 5-year high stood at $3.4 billion during Q2 2025, with a 5-year trough of $1.3 billion in Q3 2021.
  • Its 5-year average for Payables is $1.9 billion, with a median of $1.6 billion in 2022.
  • The largest annual percentage gain for Colgate Palmolive's Payables in the last 5 years was 6476.28% (2025), contrasted with its biggest fall of 1682.07% (2025).
  • Quarter analysis of 5 years shows Colgate Palmolive's Payables stood at $1.5 billion in 2021, then grew by 2.9% to $1.6 billion in 2022, then increased by 29.83% to $2.0 billion in 2023, then increased by 21.55% to $2.5 billion in 2024, then rose by 20.85% to $3.0 billion in 2025.
  • Its last three reported values are $3.0 billion in Q3 2025, $3.4 billion for Q2 2025, and $1.8 billion during Q1 2025.